Jean‐François Baurain
Cliniques Universitaires Saint-Luc · 290 works · 12,077 citations · h-index 36
Top works
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- Characterization of an Antigen That Is Recognized on a Melanoma Showing Partial HLA Loss by CTL Expressing an NK Inhibitory Receptor
- Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma
- Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034
- Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial
- Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial
- Neogenesis of Lymphoid Structures and Antibody Responses Occur in Human Melanoma Metastases
- High frequency of cytolytic T lymphocytes directed against a tumor-specific mutated antigen detectable with HLA tetramers in the blood of a lung carcinoma patient with long survival.
- A point mutation in the alpha-actinin-4 gene generates an antigenic peptide recognized by autologous cytolytic T lymphocytes on a human lung carcinoma.
- Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study
- Nivolumab for Patients With Advanced Melanoma Treated Beyond Progression
- Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study
- Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma
- Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma
- High Frequency of Autologous Anti-Melanoma CTL Directed Against an Antigen Generated by a Point Mutation in a New Helicase Gene
- Role of PET in the Initial Staging of Cutaneous Malignant Melanoma: Systematic Review
- Two antigens recognized by autologous cytolytic T lymphocytes on a melanoma result from a single point mutation in an essential housekeeping gene.
- A plain language summary of publication of the efficacy and safety of individualized niraparib dosing based on baseline body weight and platelet count in the PRIMA/ENGOT-OV26/GOG-3012 trial
- Antitumor Immunity at Work in a Melanoma Patient
- A Synopsis of Serum Biomarkers in Cutaneous Melanoma Patients